Hot Features
Premium
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Period:
Draw Mode:
| Volume | 1,049,219 |
|
|||||
| News | - | ||||||
| Day High | 24.99 | Low High |
|||||
| Day Low | 24.32 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| BridgeBio Pharma Inc | BBIO | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.72 | 2.96% | 25.05 | 17:50:57 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 24.48 | 24.32 | 24.99 | 24.88 | 24.33 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 11,861 | 1,049,219 | US$ 24.76 | US$ 25,978,890 | - | 12.75 - 44.32 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 18:43:23 | 1 | US$ 24.95 | USD |
BridgeBio Pharma (BBIO) Options Flow Summary
BridgeBio Pharma Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 4.38B | 175.83M | - | 9.3M | -643.2M | -3.66 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
BridgeBio Pharma News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical BBIO Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 24.85 | 26.2629 | 23.68 | 24.89 | 1,804,596 | 0.20 | 0.80% |
| 1 Month | 30.99 | 31.00 | 23.68 | 26.57 | 1,590,808 | -5.94 | -19.17% |
| 3 Months | 32.84 | 41.04 | 23.68 | 30.35 | 1,720,449 | -7.79 | -23.72% |
| 6 Months | 24.48 | 44.32 | 23.68 | 32.81 | 1,698,456 | 0.57 | 2.33% |
| 1 Year | 14.77 | 44.32 | 12.75 | 28.47 | 2,035,759 | 10.28 | 69.60% |
| 3 Years | 55.14 | 65.33 | 4.98 | 20.76 | 2,087,206 | -30.09 | -54.57% |
| 5 Years | 30.61 | 73.50 | 4.98 | 24.00 | 1,535,381 | -5.56 | -18.16% |
BridgeBio Pharma Description
| BridgeBio Pharma Inc is involved in identifying advance transformative medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. Its product pipeline categories include Mendelian, Genetic Dermatology, Oncology, and Gene therapy. The company focus on genetic diseases because they exist at the intersection of high unmet patient need and tractable biology. |
